Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Vildagliptin, a DPP-4 inhibitor, attenuates carbon tetrachloride-induced liver fibrosis by targeting ERK1/2, p38α, and NF-κB signaling
Rania M. Khalil, Ahmed Shata, Eman M. Abd El-Kader, et al.
Toxicology and Applied Pharmacology (2020) Vol. 407, pp. 115246-115246
Closed Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

The dynamic interplay between AMPK/NFκB signaling and NLRP3 is a new therapeutic target in inflammation: Emerging role of dapagliflozin in overcoming lipopolysaccharide-mediated lung injury
Eslam E. Abd El-Fattah, Sameh Saber, Ahmed A.E. Mourad, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 147, pp. 112628-112628
Open Access | Times Cited: 57
A Novel Combination Therapy Using Rosuvastatin and Lactobacillus Combats Dextran Sodium Sulfate-Induced Colitis in High-Fat Diet-Fed Rats by Targeting the TXNIP/NLRP3 Interaction and Influencing Gut Microbiome Composition
Sameh Saber, Eslam E. Abd El-Fattah, Galal Yahya, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 4, pp. 341-341
Open Access | Times Cited: 55
Role of Dipeptidyl Peptidase 4 Inhibitors in Antidiabetic Treatment
Ruili Yin, Yongsong Xu, Xin Wang, et al.
Molecules (2022) Vol. 27, Iss. 10, pp. 3055-3055
Open Access | Times Cited: 49
BBG enhances OLT1177-induced NLRP3 inflammasome inactivation by targeting P2X7R/NLRP3 and MyD88/NF-κB signaling in DSS-induced colitis in rats
Sameh Saber, Mahmoud E. Youssef, Hossam Sharaf, et al.
Life Sciences (2021) Vol. 270, pp. 119123-119123
Closed Access | Times Cited: 53
Ambroxol, a mucolytic agent, boosts HO‐1, suppresses NF‐κB, and decreases the susceptibility of the inflamed rat colon to apoptosis: A new treatment option for treating ulcerative colitis
Simona Cavalu, Hossam Sharaf, Sameh Saber, et al.
The FASEB Journal (2022) Vol. 36, Iss. 9
Open Access | Times Cited: 32
Coomassie brilliant blue G-250 dye attenuates bleomycin-induced lung fibrosis by regulating the NF-κB and NLRP3 crosstalk: A novel approach for filling an unmet medical need
Mona H. Zohny, Simona Cavalu, Mahmoud E. Youssef, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 148, pp. 112723-112723
Open Access | Times Cited: 29
Albendazole-loaded cubosomes interrupt the ERK1/2-HIF-1α-p300/CREB axis in mice intoxicated with diethylnitrosamine: A new paradigm in drug repurposing for the inhibition of hepatocellular carcinoma progression
Sameh Saber, Mohamed Nasr, Ahmed S. Saad, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 142, pp. 112029-112029
Open Access | Times Cited: 40
Empagliflozin adjunct with metformin for the inhibition of hepatocellular carcinoma progression: Emerging approach for new application
A. M. Abdelhamid, Sameh Saber, Mahmoud E. Youssef, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 145, pp. 112455-112455
Open Access | Times Cited: 40
Blunting p38 MAPKα and ERK1/2 activities by empagliflozin enhances the antifibrotic effect of metformin and augments its AMPK-induced NF-κB inactivation in mice intoxicated with carbon tetrachloride
A. M. Abdelhamid, Mahmoud E. Youssef, Eslam E. Abd El-Fattah, et al.
Life Sciences (2021) Vol. 286, pp. 120070-120070
Open Access | Times Cited: 33
Electrocardiographic and histopathological characterizations of diabetic cardiomyopathy in rats
Mahmoud E. Youssef, Mona F. El-Azab, Marwa A. Abdel-Dayem, et al.
Environmental Science and Pollution Research (2021) Vol. 29, Iss. 17, pp. 25723-25732
Open Access | Times Cited: 32
Does DPP-IV Inhibition Offer New Avenues for Therapeutic Intervention in Malignant Disease?
Petr Bušek, Jonathan S. Duke‐Cohan, Aleksi Šedo
Cancers (2022) Vol. 14, Iss. 9, pp. 2072-2072
Open Access | Times Cited: 26
Carbocisteine as a Modulator of Nrf2/HO-1 and NFκB Interplay in Rats: New Inspiration for the Revival of an Old Drug for Treating Ulcerative Colitis
A. M. Abdelhamid, Mahmoud E. Youssef, Simona Cavalu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 23
AKT-AMPKα-mTOR-dependent HIF-1α Activation is a New Therapeutic Target for Cancer Treatment: A Novel Approach to Repositioning the Antidiabetic Drug Sitagliptin for the Management of Hepatocellular Carcinoma
Eslam E. Abd El-Fattah, Sameh Saber, Mahmoud E. Youssef, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 22
Inhibiting DPP4 activity protects hiPSC-derived steatotic HLCs by supporting fatty acid and purine metabolism and dampening inflammation
Christiane Lörch, Wasco Wruck, R. J. Julian, et al.
Research Square (Research Square) (2025)
Open Access
Design, discovery, molecular docking, dynamics and in-silico ADME-T evaluation of novel hybrids of 1,3,5-triazine-morpholino-thiazine as an anti-diabetic agent in Wistar rats via inhibition of DPP-4
Akanksha Gupta, Ananya Anurag Anand, Sintu Kumar Samanta, et al.
Journal of Molecular Structure (2025), pp. 141707-141707
Closed Access
The Supportive Role of NSC328382, a P2X7R Antagonist, in Enhancing the Inhibitory Effect of CRID3 on NLRP3 Inflammasome Activation in Rats with Dextran Sodium Sulfate-Induced Colitis
Sameh Saber, Galal Yahya, Naglaa A. Gobba, et al.
Journal of Inflammation Research (2021) Vol. Volume 14, pp. 3443-3463
Open Access | Times Cited: 31
Renoprotective Effects of DPP-4 Inhibitors
Daiji Kawanami, Yuichi Takashi, Hiroyuki Takahashi, et al.
Antioxidants (2021) Vol. 10, Iss. 2, pp. 246-246
Open Access | Times Cited: 28
Vildagliptin alleviates liver fibrosis in NASH diabetic rats via modulation of insulin resistance, oxidative stress, and inflammatory cascades
Ahmed S. Hendawy, Naglaa M. El-Lakkany, Eman M. Mantawy, et al.
Life Sciences (2022) Vol. 304, pp. 120695-120695
Closed Access | Times Cited: 19
STA9090 as a Potential Therapeutic Agent for Liver Fibrosis by Modulating the HSP90/TβRII/Proteasome Interplay: Novel Insights from In Vitro and In Vivo Investigations
Osama A. Mohammed, Mustafa Ahmed Abdel‐Reheim, Mohannad Mohammad S. Alamri, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 8, pp. 1080-1080
Open Access | Times Cited: 12
Combination of metformin and hesperidin mitigates cyclophosphamide-induced hepatotoxicity. Emerging role of PPAR-γ/Nrf-2/NF-κB signaling pathway
Kareman M. El-Beheiry, Magda El‐Sayed El‐Sayad, Thanaa A. El‐Masry, et al.
International Immunopharmacology (2023) Vol. 117, pp. 109891-109891
Closed Access | Times Cited: 11
Nifuroxazide-loaded cubosomes exhibit an advancement in pulmonary delivery and attenuate bleomycin-induced lung fibrosis by regulating the STAT3 and NF-κB signaling: A new challenge for unmet therapeutic needs
Sameh Saber, Mohamed Nasr, Mohamed M.Y. Kaddah, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 148, pp. 112731-112731
Open Access | Times Cited: 18
Regulatory network and interplay of hepatokines, stellakines, myokines and adipokines in nonalcoholic fatty liver diseases and nonalcoholic steatohepatitis
Bing Yang, Liqing Lu, Dongmei Zhou, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 17
Targeting cluster of differentiation 26 / dipeptidyl peptidase 4 (CD26/DPP4) in organ fibrosis
Birte Ohm, Isabelle Moneke, Wolfgang Jungraithmayr
British Journal of Pharmacology (2022) Vol. 180, Iss. 22, pp. 2846-2861
Open Access | Times Cited: 17
Potential Antitumor Activity of Combined Lycopene and Sorafenib against Solid Ehrlich Carcinoma via Targeting Autophagy and Apoptosis and Suppressing Proliferation
Thanaa A. El‐Masry, Maysa M. F. El-Nagar, Nageh Ahmed El Mahdy, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 4, pp. 527-527
Open Access | Times Cited: 3
Vildagliptin ameliorates intrapulmonary vasodilatation and angiogenesis in chronic common bile duct ligation-induced hepatopulmonary syndrome in rat
Safwat A. Mangoura, Marwa A Ahmed, Nashwa Hamad, et al.
Clinics and Research in Hepatology and Gastroenterology (2024) Vol. 48, Iss. 7, pp. 102408-102408
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top